An update on current pharmacotherapy for vulvar cancer

G Bogani, I Palaia, G Perniola, F Tomao… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction Limited data on the role of pharmacotherapy for patients with locally advanced,
recurrent, or metastatic vulvar cancer are available. Areas covered This article aims to …

Risk for pelvic metastasis and role of pelvic lymphadenectomy in node-positive vulvar cancer-results from the AGO-VOP. 2 QS vulva study

L Woelber, M Hampl, CZ Eulenburg, K Prieske… - Cancers, 2022 - mdpi.com
Simple Summary In node-positive vulvar squamous cell cancer, questions of when and how
to perform pelvic lymphadenectomy (LAE) as well as the optimal extent of pelvic treatment in …

Pelvic lymphadenectomy in vulvar cancer and its impact on prognosis and outcome

A Jaeger, K Prieske, S Mathey, I Fischer… - Archives of Gynecology …, 2022 - Springer
Background The value of pelvic lymphadenectomy (LAE) has been subject of discussions
since the 1980s. This is mainly due to the fact that the relation between lymph node …

Clinical Impact of Pelvic Sentinel Lymph Node Biopsy for Vulvar Squamous Cell Carcinoma

B Morgenstern, F Thangarajah, M Schmidt… - Anticancer …, 2024 - ar.iiarjournals.org
Background/Aim: This study investigated the clinical impact of resection of pelvic sentinel
lymph nodes (PSLNs) in squamous cell vulvar cancer (SCVC). Patients and Methods: Sixty …

Pelvic Lymphadenectomy in Vulvar Cancer–Does it make sense?

L Woelber, M Bommert, K Prieske… - Geburtshilfe und …, 2020 - thieme-connect.com
Seit der Veröffentlichung der aktualisierten deutschen Leitlinie 2015 hat sich die
Empfehlung zur pelvinen Lymphonodektomie (LNE) bei Patientinnen mit Vulvakarzinom …

Pelvine Lymphonodektomie beim Vulvakarzinom-Wohl oder Übel?

L Woelber, M Bommert, K Prieske, I Fischer… - Geburtshilfe und …, 2020 - research.rug.nl
Since the publication of the updated German guideline in 2015, the recommendations for
performing pelvic lymphadenectomy (LAE) in patients with vulvar cancer (VSCC) have …